Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Retension Pharmaceuticals, Inc.
13G
76135H100
|
10.0% |
10/16/2026
Event 10/13/2026
|
|||
| The B Group, Inc. | 10.0% | ||||
| B Group Capital LLC | 10.0% | ||||
| Branden B. Muhl | 10.0% | ||||
|
NRx Pharmaceuticals, Inc.
13G
NRXP · 629444209
|
12.6% |
8/21/2025
Event 8/18/2025
|
|||
| The B Group, Inc. | 12.6% | ||||
| B Group Capital LLC | 12.6% | ||||
| Branden B. Muhl | 12.6% | ||||